A single step synthesis of 6-aminophenanthridines from anilines and 2-chlorobenzonitriles

Tuning the Photophysical Properties of Homoleptic Tris-Cyclometalated Ir(III) Complexes by Facile Modification of the Imidazo-Phenanthridine and Their Application to Phosphorescent Organic Light-Emitting Diodes

To explore the excited-state electronic structure of the blue-emitting Ir(dmp)₃ dopant material (dmp = 3-(2,6-dimethylphenyl)-7-methylimidazo[1,2-f]phenanthridine), which is notable for durable blue phosphorescent organic light-emitting diode (PhOLED), a series of homoleptic dmp-based Ir(III) complexes (DMP-R, tris[3-(2,6-dimethylphenyl)-7-R-imidazo[1,2-f]phenanthridin-12-yl-κC ¹²,κN ¹]iridium, R = H, CH₃, F, and CF₃) were prepared by introducing an electron-donating group (EDG; -CH₃) or an electron-withdrawing group (EWG; -F and -CF₃) at the 7-position of the imidazo-phenanthridine ligand. The photophysical analysis demonstrated that the alteration from EDG to EWGs led to redshifted structureless emission profiles, which were correlated with variations in the ³MLCT/³ILCT ratio in the T₁ excited state. From electrochemical studies and density functional theory calculations, it turned out that the excited-state nature of the dmp-based Ir(III) complexes was significantly affected by the inductive effect of the 7-substituent of the cyclometalating dmp ligand. As a result of the lowest unoccupied molecular orbital energy stabilization by the EWGs that suppressed the non-radiative pathway from the emissive triplet excited state to the ³ d-d state, the F- and CF₃-modified Ir(dmp)₃ complexes (DMP-F and DMP-CF ₃ ) showed quantum yields of 27-30% in the solution state, which were at least 4- or 5-fold higher than those shown by DMP-H and DMP-CH ₃ . A PhOLED device based on DMP-CF ₃ [CIE chromaticity (0.17, 0.39)], which demonstrated a distinct ³MLCT characteristic, exhibited better electroluminescent efficiencies with an external quantum efficiency of 13.5% than that based on DMP-CH ₃ .

Synthesis of indenophenanthridine via a [4+2] annulation strategy: a “turn-off’’ Fe3+ ion sensor, practical application in live cell imaging and reversible acidochromism studies

An efficient protocol has been developed for the synthesis of a novel fluorescent probe, 1,2-disubstituted-indeno[1,2,3-gh]phenanthridine, derived from a series of α-oxo-ketene dithioacetals (OKDTAs) and indenoquinoline under essential conditions via a [4+2] annulation in excellent yield.

Calcium mediated efficient synthesis of N-arylamidines from organic nitriles and amines

Amidines are a preeminent group of organic compounds having wide applications in various industries. Here, we have developed a simple one-step reaction protocol for the facile synthesis of N-arylamidines catalysed by calcium bis(hexamethyldisilazide) [Ca{N(SiMe3)2}2(THF)2]. The amidine synthesis was readily achieved from organic nitriles and amines which provided a broad substrate scope ranging from electron-withdrawing to electron-donating substitutions as well as heterocyclic substitution. The reaction was carried out in a solvent-free medium under ambient conditions. The nucleophilic addition of aromatic amines to aryl nitriles led to good to excellent yields of the corresponding amidines. The reactivity of the amidines was further examined and the respective urea derivatives were achieved in excellent yields. The plausible mechanism involves the generation of an active calcium amido pre-catalyst that helps in the activation of nitriles in the reaction course.

Synthesis of 6-aminophenanthridines via palladium-catalyzed insertion of isocyanides into N-sulfonyl-2-aminobiaryls

A robust route to a diverse set of 6-aminophenanthridines via palladium-catalyzed C–H activation of N-sulfonyl-2-aminobiaryl and isocyanide insertion is reported.

Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding

The ribosome, the protein synthesis machinery of the cell, has also been implicated in protein folding. This activity resides within the domain V of the main RNA component of the large subunit of the ribosome. It has been shown that two antiprion drugs 6-aminophenanthridine (6AP) and Guanabenz (GA) bind to the ribosomal RNA and inhibit specifically the protein folding activity of the ribosome. Here, we have characterized with biochemical experiments, the mode of inhibition of these two drugs using ribosomes or ribosomal components active in protein folding (referred to as 'ribosomal folding modulators' or RFMs) from both bacteria Escherichia coli and yeast Saccharomyces cerevisiae, and human carbonic anhydrase (HCA) as a sample protein. Our results indicate that 6AP and GA inhibit the protein folding activity of the ribosome by competition with the unfolded protein for binding to the ribosome. As a result, the yield of the refolded protein decreases, but the rate of its refolding remains unaffected. Further, 6AP- and GA mediated inhibition of RFM mediated refolding can be reversed by the addition of RFMs in excess. We also demonstrate with delayed addition of the ribosome and the antiprion drugs that there is a short time-span in the range of seconds within which the ribosome interacts with the unfolded protein. Thus we conclude that the protein folding activity of the ribosome is conserved from bacteria to eukaryotes and most likely the substrate for RFMs is an early refolding state of the target protein.

Synthesis of conjugates of 6-aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatography

The synthesis of affinity matrices for 6-aminophenanthridine (6AP) and 2,6-dichlorobenzylidenaminoguanidine (Guanabenz, GA), two unrelated prion inhibitors, is described. In both cases, the same simple spacer, epsilon-aminocaproylaminopentanol, was introduced by a Mitsunobu reaction and the choice of the anchoring position of the linker was determined by the study of the residual antiprion activity of the corresponding 6AP or GA conjugates. Very recently, these two affinity matrices were used for chromatography assays leading to the identification of ribosome (via the rRNA) as a common target of these two antiprion drugs. Here, we show, using competition experiments with Quinacrine (QC) and Chlorpromazine (CPZ), two other antiprion drugs, that QC, but not CPZ, may also directly target the rRNA.